Literature DB >> 26674761

Plasma Concentrations of Trimethylamine-N-oxide Are Directly Associated with Dairy Food Consumption and Low-Grade Inflammation in a German Adult Population.

Sabine Rohrmann1, Jakob Linseisen2, Martina Allenspach3, Arnold von Eckardstein3, Daniel Müller3.   

Abstract

BACKGROUND: Trimethylamine-N-oxide (TMAO) is a metabolite of carnitine, choline, and phosphatidylcholine, which is inversely associated with survival of cardiovascular disease (CVD) patients.
OBJECTIVE: We examined the associations of diet with plasma concentrations of TMAO, choline, and betaine and the associations of TMAO with plasma concentrations of various cytokines.
METHODS: Plasma TMAO, choline, and betaine concentrations were measured using LC-high resolution mass spectrometry in 271 participants, ≥18 y old, of the Second Bavarian Food Consumption Survey, conducted in 2002 and 2003. Food consumption was assessed using at least two 24-h dietary recalls. Cytokines were measured in plasma with enzyme-linked immunosorbent assays. Geometric mean concentrations of TMAO, choline, and betaine by categories of meat, dairy food, egg, and fish consumption were computed, adjusted for sex, age, and BMI. Multivariable-adjusted geometric mean concentrations of cytokines [tumor necrosis factor-α (TNF-α), soluble TNF receptors (sTNF-R) p55, sTNF-R p75, interleukin-6 (IL-6), and C-reactive protein (CRP)] were computed by quartiles of TMAO concentration using general linear models.
RESULTS: Meat, egg, or fish consumption was not associated with TMAO, choline, or betaine concentrations (all P-trend ≥ 0.05). With increases in milk and other dairy food consumption, the plasma TMAO concentration increased [geometric mean bottom quartile of milk consumption: 2.08 μM (95% CI: 1.69, 2.57 μM); compared with top quartile: 3.13 μM (95% CI: 2.56, 3.84 μM); P-trend = 0.008]. Participants in the top TMAO quartile had higher plasma concentrations of TNF-α, sTNF-R p55, and sTNF-R p75 than participants in the bottom quartile (percentage difference ranging between 14.4% and 17.3%; all P-trend < 0.05), but there were no differences in plasma concentrations of CRP and IL-6 (all P-trend ≥ 0.05).
CONCLUSIONS: Results of this study conducted among healthy adults from the general population do not indicate a strong effect of diet on plasma concentrations of TMAO, choline, or betaine, with the exception of a positive association between dairy food consumption and plasma TMAO concentrations. Also, plasma TMAO concentrations were positively associated with inflammation. Whether habitual diet is strongly linked to the plasma TMAO concentration, a potential marker of CVD risk, needs to be determined in further studies.
© 2016 American Society for Nutrition.

Entities:  

Keywords:  Trimethylamine-N-oxide; cheese; inflammation; milk; red meat

Mesh:

Substances:

Year:  2015        PMID: 26674761     DOI: 10.3945/jn.115.220103

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  61 in total

Review 1.  Targeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.

Authors:  J Mark Brown; Stanley L Hazen
Journal:  J Biol Chem       Date:  2017-04-07       Impact factor: 5.157

2.  Plasma trimethylamine N-oxide, a gut microbe-generated phosphatidylcholine metabolite, is associated with autism spectrum disorders.

Authors:  Lijuan Quan; Jinping Yi; Yue Zhao; Feng Zhang; Xiao-Tong Shi; Zhen Feng; Haylie L Miller
Journal:  Neurotoxicology       Date:  2019-11-05       Impact factor: 4.294

3.  Relationship between serum trimethylamine N-oxide and exposure to dioxin-like pollutants.

Authors:  Michael C Petriello; Richard Charnigo; Manjula Sunkara; Sony Soman; Marian Pavuk; Linda Birnbaum; Andrew J Morris; Bernhard Hennig
Journal:  Environ Res       Date:  2018-01-30       Impact factor: 6.498

4.  Plasma trimethylamine-N-oxide and related metabolites are associated with type 2 diabetes risk in the Prevención con Dieta Mediterránea (PREDIMED) trial.

Authors:  Christopher Papandreou; Mònica Bulló; Yan Zheng; Miguel Ruiz-Canela; Edward Yu; Marta Guasch-Ferré; Estefanía Toledo; Clary Clish; Dolores Corella; Ramon Estruch; Emilio Ros; Montserrat Fitó; Fernando Arós; Miquel Fiol; José Lapetra; Lluís Serra-Majem; Enrique Gómez-Gracia; Liming Liang; Georgios A Fragkiadakis; Cristina Razquin; Frank B Hu; Jordi Salas-Salvadó
Journal:  Am J Clin Nutr       Date:  2018-07-01       Impact factor: 7.045

Review 5.  Trimethylamine N-oxide: breathe new life.

Authors:  Saravanan Subramaniam; Craig Fletcher
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

6.  Trimethylamine-N-oxide and its biological variations in vegetarians.

Authors:  Rima Obeid; Hussain M Awwad; Markus Keller; Juergen Geisel
Journal:  Eur J Nutr       Date:  2016-08-25       Impact factor: 5.614

7.  Gut microbiota metabolites, amino acid metabolites and improvements in insulin sensitivity and glucose metabolism: the POUNDS Lost trial.

Authors:  Yoriko Heianza; Dianjianyi Sun; Xiang Li; Joseph A DiDonato; George A Bray; Frank M Sacks; Lu Qi
Journal:  Gut       Date:  2018-06-02       Impact factor: 23.059

8.  Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.

Authors:  Signe A Winther; Jens C Øllgaard; Nete Tofte; Lise Tarnow; Zeneng Wang; Tarunveer S Ahluwalia; Anders Jorsal; Simone Theilade; Hans-Henrik Parving; Tine W Hansen; Stanley L Hazen; Oluf Pedersen; Peter Rossing
Journal:  Diabetes Care       Date:  2019-05-23       Impact factor: 19.112

9.  Diets high in resistant starch increase plasma levels of trimethylamine-N-oxide, a gut microbiome metabolite associated with CVD risk.

Authors:  Nathalie Bergeron; Paul T Williams; Regina Lamendella; Nastaran Faghihnia; Alyssa Grube; Xinmin Li; Zeneng Wang; Rob Knight; Janet K Jansson; Stanley L Hazen; Ronald M Krauss
Journal:  Br J Nutr       Date:  2016-12-20       Impact factor: 3.718

10.  Genome- and CD4+ T-cell methylome-wide association study of circulating trimethylamine-N-oxide in the Genetics of Lipid Lowering Drugs and Diet Network (GOLDN).

Authors:  Stella Aslibekyan; Marguerite R Irvin; Bertha A Hidalgo; Rodney T Perry; Elias J Jeyarajah; Erwin Garcia; Irina Shalaurova; Paul N Hopkins; Michael A Province; Hemant K Tiwari; Jose M Ordovas; Devin M Absher; Donna K Arnett
Journal:  J Nutr Intermed Metab       Date:  2017-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.